AKT1 and metabolic dysfunction-associated steatotic liver disease: Hyperinsulinemia and deregulated insulin signaling occur in obesity, type 2 diabetes and NAFLD, and insulin activates PI3K/Akt signaling, a key regulator of metabolism, cell growth and cell survival.